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Abstract 
Palmitic acid (PA) and oleic acid (OA) are the most abundant saturated and monounsaturated non-
esterified fatty acids, respectively, in serum. The consequences of PA and OA treatment on 
preimplantation mouse embryo development were investigated. It was hypothesized that OA 
treatment from the two-cell stage onwards would attenuate PA-induced reductions in mouse 
blastocyst development. PA significantly reduced development to the blastocyst stage. Transcript 
analysis revealed that PA increased ER stress pathway markers activating transcription factor 3 
and C/EBP homologous protein transcripts, and XBP1 splicing. Co-culture of PA-treated embryos 
with OA prevented this PA-induced ER stress and rescued blastocyst development. Cytoplasmic 
lipid droplet accumulation was significantly increased by OA co-treatment. The results indicate 
that PA treatment induces ER stress, which limits lipid droplet accumulation and impairs 
blastocyst development. Co-treatment with OA is protective in reducing PA-induced ER stress and 
developmental impairments. These findings have applications in improving fertility outcomes for 
obese patients.   
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Chapter 1  
1 Introduction 
1.1 Assisted Reproductive Technologies 
Human infertility is a global problem1, affecting 1 in 6 couples2 worldwide. Over the past 
40 years assisted reproductive technologies (ARTs) have been developed to help couples 
conceive. These ARTs encompass a wide variety of fertility treatments2 including 
intrauterine insemination (IUI); controlled ovarian stimulation (COS);  in vitro oocyte 
maturation (IVM), in vitro fertilization (IVF),  intracytoplasmic sperm injection (ICSI), 
embryo culture, oocyte and embryo cryopreservation, preimplantation genetic assessment 
(PGA) and single embryo transfer (SET), to name the most common procedures. 
Some ARTs address female-factor infertility, while others such as ICSI address male factor 
infertility. Regardless of the underlying etiology of this infertility it is necessary that a 
developmentally competent oocyte be retrieved from a female, whether it be from the 
future mother or provided via an oocyte donor3. The majority of oocytes are retrieved 
following application of one of many routinely employed hormonal gonadotrophin-based 
ovarian stimulation protocols4. In some cases, an alternative approach involves the 
collection of immature oocytes which are then matured in vitro by applying in vitro oocyte 
maturation methods. COS promotes follicular recruitment and oocyte maturation in vivo of 
a larger pool of oocytes than natural cycles provide5,6. In clinics, oocyte maturation is 
promoted through gonadotropin (follicle stimulating hormone (FSH) and then luteinizing 
hormone (LH)) injections which “rescue” subordinate ovarian follicles from atretic 
pathways thus fostering greater follicular recruitment and development of substantially 
more mature Graafian follicles in the ovary. Cumulus-oocytes complexes (COCs) are 
retrieved from ovarian follicles7–9 and used downstream as necessary in the clinic. The 
oocyte is fertilized by sperm, most commonly through IVF or ICSI, to form a zygote. This 
zygote is placed into in vitro culture to increasingly support development to the blastocyst 
stage, when SET can be applied to transfer the embryo into a female’s uterus for 
implantation and initiation of a pregnancy.  
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All of these procedures while commonly applied today, were developed and put into 
practice as a result of extensive amounts of research globally. Studies deciphered the key 
mechanisms controlling mammalian reproduction in various animal models, which were 
translated and applied to humans over the past 100 years of scientific inquiry. These efforts 
culminated in 2010 when Dr. Bob Edwards received the Nobel prize in Physiology for his 
efforts with Dr. Patrick Steptoe that resulted in the birth of the world’s very first IVF child, 
Louise Brown in 197810. However, despite all of its successes, human fertility medicine 
only results in a 50-65% pregnancy rate of all patients seeking fertility treatment11.  
The ART process can be broken down into several stages: oocyte maturation and 
collection, fertilization, preimplantation development, embryo transfer and implantation, 
and pregnancy. Each of these stages and procedures still require significant improvement 
if we are to achieve the goal of helping everyone who seeks fertility treatment succeed in 
their quest of having a family. The research in this thesis is directed at specifically 
improving our ability to support preimplantation development in vitro so that only 
blastocysts with high developmental competence are transferred during SET. The potential 
implications of this thesis are to further explore the struggles faced by the obese patient as 
these patients are increasing dramatically in number in the global population, and their 
struggle to conceive is much greater than that of healthy BMI patients12–14. Although this 
research was not clinical in nature, understanding the mechanisms that are altered in the 
embryo during the ART process opens the door to translating information into human 
fertility clinics.  
Thus, my studies have focused on investigating preimplantation development and how 
changes in the in vitro culture environment affect the mouse embryo during this stage. The 
mouse preimplantation embryo is employed since it has become a primary research model 
for understanding the mechanisms controlling mammalian preimplantation development 
and it shares many mechanisms that have also been observed within human 
preimplantation embryos15,16. As a first step toward a longer-term goal of increasing 
success of fertility treatment for obese women, we initiated a number of studies looking at 
the direct influence of specific non-esterified fatty acids (NEFAs) on preimplantation 
mouse embryos. 
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1.2 Preimplantation Embryo Development 
Preimplantation development is the term defining the period between fertilization of an 
oocyte to form an embryo and implantation of said embryo in the uterus (Figure 1). With 
fertilization occurring in the oviduct (also known as the fallopian tube), the ovulated oocyte 
merges with a single sperm to create a single cell zygote17. This embryo undergoes repeated 
cellular divisions as it travels toward the uterus. With each division, the number of cells in 
the embryo, each of which is termed a blastomere, increases exponentially. However due 
to the fact that the cells do not undergo a period of growth before dividing, blastomeres 
decrease in size with each division. The zygote becomes a 2-cell, then a 4-cell, and at the 
8-cell embryo18,19 stage adherens junctions form, followed by tight junctions 16,18,20,21. The 
formation of cell-to-cell junctions of the outer cells of the embryo leads to their cellular 
compaction, after which individual blastomere borders cannot be differentiated. 
Compaction creates a morula that later cavitates to form a blastocyst, which has a fluid-
filled cavity18,19.  
The blastocyst is composed of the inner cell mass (ICM), fluid-filled cavity, and an outer 
layer of epithelial trophectoderm cells16. The ICM later gives rise to embryonic tissues, 
while the trophectoderm produces extraembryonic tissues such as the placenta, which 
support embryonic and fetal development during pregnancy16. In late stage blastocysts the 
ICM differentiates into two distinct cell types: the epiblast and primitive endoderm16. For 
the purpose of this study, we defined a blastocyst as being a preimplantation embryo with 
a visible fluid-filled cavity. Implantation of the blastocyst in the uterus marks the end of 
preimplantation development. In the mouse, zygote corresponds to embryonic day 0.5 
(E0.5), the 2-cell to E1.5, the 4-cell to E2.0, the 8-cell to E2.25, the morula to E3.0, and 
the early blastocyst to E3.516. Although the timing differs slightly between humans and 
mice, the mouse embryo passes through the same stages as the human embryo, making it 
an excellent model for understanding human preimplantation development (Figure 1). 
With the application of SET to ARTs the human preimplantation period increasingly 
occurs in vitro, thus, it is essential that culture conditions be optimized for different 
patients’ embryos. Our lab has been studying the role of the in vitro culture environment 
on blastocyst development for almost 30 years22,23.  
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Figure 1. Preimplantation embryo development in the mouse (A) and human (B). 
Human and mouse preimplantation embryos progress through the same stages of 
preimplantation development, with the human taking 1.5 days longer than that mouse to 
reach the late blastocyst stage. A) Timing and stages of preimplantation embryo 
development in the mouse. B) Timing and stages of preimplantation embryo development 
in the human. Figure adapted from Cockburn and Rossant, 201016. 
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1.3 Development of embryo culture environments in fertility 
clinics  
Although ARTs are fundamental for treating human infertility and fostering conception, 
pregnancy and live births, there is a requirement for significant improvement in each phase 
of the ARTs fertility treatment continuum. Obtaining a mature oocyte that has attained high 
developmental competence is an essential step in every IVM, IVF and ICSI protocol. In 
vivo, gonadotrophin stimulation cycles can be used to mature oocytes. Alternatively, an 
immature oocyte can be removed from the ovary and matured in vitro (IVM)24–26.  
IVM is becoming increasingly more common, due to suspected complications, such as 
ovarian hyperstimulation syndrome, that can arise from elevated gonadotrophin level 
exposure resulting from COS protocols27–29. Unfortunately, survival of oocytes matured in 
vitro is  lower than  that of oocytes matured in vivo30. It is suspected that subpar culture 
environment likely underlies this decreased success with IVM oocytes. Supplementing 
oocyte culture media during IVM with different factors, such as autocrine and paracrine 
regulators including epidermal growth factor (EGF)31,32 and growth differentiation factor 
9 (GDF9)33 to increase an oocyte’s developmental competence have been extensively 
investigated. Similarly, supplementing preimplantation embryo culture media with growth 
factors, amino acids, metabolic substrates etc. can improve the embryos’ developmental 
competence34,35. Watson et al. showed that inclusion of amino acids and epidermal growth 
factor (EGF) to culture media resulted in significantly more bovine oocytes developing to 
the blastocyst stage31. Additionally, supplementation of oocyte culture medium with 
GDF933 and antioxidants36 increases viability of embryos derived from IVM oocytes. 
Embryo culture presents with similar challenges to oocyte culture, where optimized culture 
media must be developed to improve embryo viability and fertility outcomes. 
Past research has allowed for the investigation of and development of a standard embryo 
culture medium which is used in fertility clinics today37. By optimizing the embryo culture 
environment: 
1) Less embryos will be lost/developmentally arrested.  
2) More embryos will develop to a stage where they can be transferred or 
cryopreserved. 
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3) Embryo developmental competence will be enhanced improving outcomes for 
embryo transfer/implantation, and live birth rates.  
Overall, the outcome of in vitro culture optimization research is that the ART process will 
be made more efficient, less wasteful, and less taxing on individuals undergoing fertility 
treatments. The fertility treatment process is stressful both psychologically, physically38,39 
and financially40 on patients. Optimizing this process to minimize the stressors faced by 
future parents is an invaluable outcome of this and future research. 
1.4 Advances in embryo culture developed in the lab  
Our lab has been studying the in vitro embryo culture environment. Altering and 
understanding how changes in this culture environment affect preimplantation 
development is a useful tool in two ways.  
Firstly, changing the mouse preimplantation embryo culture environment allows us to 
model the human in vitro culture environment in fertility clinics. By experimenting with 
changes in media, timing of culture, and the incubation environment, we are able to model 
and discover ways to improve embryo culture. Thus, this research contributes to optimizing 
the in vitro culture environment and improving ART outcomes.  
Secondly, changing the composition of media in vitro helps us understand embryo 
physiology and how embryos may be responding to different in vivo environments. Since 
this is difficult to study in vivo, in vitro culture provides us with a model to directly study 
the mechanistic and developmental alterations that happen when embryos are exposed to 
different environments, providing us with insight into what may be happening in vivo. For 
example, the focus of the studies presented in this thesis was on modeling how varying 
fatty acid levels in vivo may affect embryo development in mothers of low, moderate, or 
high body mass indices (BMIs). Studying how high fatty acid levels individually and in 
combination affect embryo development in vitro provides some insight into how a 
condition as complex as obesity may be affecting preimplantation embryo development 
and restricting conception success in obese patients seeking assistance from fertility clinics. 
Potassium simplex optimization medium (KSOM) has been optimized to allow for 
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successful development of mouse embryos to the blastocyst stage41, however KSOM media 
is not supplemented with any fats42.  The experiments in this thesis take a reductionist 
approach to understanding the complexity of how obesity affects embryo development and 
focuses in on investigating a single factor (NEFA levels) and elucidating its effect on 
preimplantation embryo development.  
1.5 Reproductive Disorders Associated with Obesity 
The prevalence of obesity has been increasing not only nationally but internationally. The 
World Health Organization (WHO) classifies overweight and obesity by body mass index 
(BMI), which takes into account an individual’s height and weight43. Based on BMI, 
individuals can be categorized into several categories: 1) <18.5 kg/m2 (underweight), 2) 
18.5-24.9 kg/m2 (normal weight), 3) 25-29.9 kg/m2 (overweight), and 4) >30 kg/m2 
(obese)44. In Canada, the incidence of female obesity reached 18.7% in 2014, a 4.2% 
increase from 200345. In 2017, Statistics Canada reported that 1.87 million and 1.61 million 
women of reproductive age (18-49 years old) were overweight or obese, respectively45. 
Obesity is associated with increased disease risk and infertility in both males46 and 
females47. With increasing BMIs, women display increased incidence of reproductive 
disorders than women at normal BMIs. These include, but are not limited to, ovarian, 
uterine, and tubal disorders48. Given that obese women have greater difficulty conceiving, 
they are more likely to seek fertility treatments and make use of ARTs. Unfortunately, 
publications have reported poorer outcomes for obese women after seeking fertility 
treatment48–51. 
With ARTs, women often undergo ovarian hyperstimulation through hormonal injections. 
Obese women have been shown to have decreased responses to gonadotropins used for 
ovarian hyperstimulation, and thus, require higher doses of hormones when undergoing 
ovarian hyperstimulation48,52. With increasing BMI, the number of oocytes successfully 
collected decreases52,53. Thus, regardless of increased gonadotropin doses, obesity is 
associated with significantly greater risk of unsuccessful ovarian stimulation cycles48. IVF 
or ICSI in obese women does not affect their ability to become clinically pregnant51, 
however obese women were at a higher risk for early and recurrent pregnancy loss52,54 and 
miscarriage 51 than their normal BMI counterparts.  During pregnancy, obese women have 
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a higher prevalence of gestational diabetes54. Consequently, live birth rates are also reduced 
with obesity48. The mechanisms underlying the negative effects of obesity on a women’s 
reproductive capacity are not well understood and must be investigated to assist this rapidly 
growing patient population.  
1.6 Palmitic Acid and Oleic Acid: Source and Structure 
NEFAs are free fatty acid (FFA) molecules found primarily bound to albumin55 in 
circulation. High BMI is associated with elevated NEFA levels in vivo56. Palmitic acid 
(16:0, PA, Figure 2A) is the most abundant NEFA in circulation57,58, the Western diet59, 
and in human follicular fluid phospholipids60. While PA is the most abundant saturated 
NEFA, oleic acid (18:1, OA, Figure 3B) is the most abundant monounsaturated NEFA 57. 
With obesity, there is a marked increase in body fat content, which thereby causes elevated 
levels of NEFAs in the circulation of obese individuals61. In the serum of lean individuals, 
PA and OA each exist in a 1:1 ratio62 at roughly 100 M concentrations, however these 
levels are higher in obese individuals at 200-400 M58,63,64. Although PA and OA 
concentrations in the female reproductive tract remain unknown, their abundance 
elsewhere in the body suggests that PA and OA are primary saturated NEFAs that embryos 
are exposed to during preimplantation development.  
PA in the body is sourced from the diet or through de novo synthesis65. Although PA and 
OA structurally differ by only two carbons and a single double bond, these NEFAs have 
been shown to have different metabolic fates66. PA, but not OA, was associated with higher 
diabetes risk67. Bakke et al investigated the effect of 100 M PA or 100 M OA on skeletal 
muscle. They found that relative to OA, PA resulted in lower lipolysis, incorporates more 
into phospholipids than TAGS, increased lipogenesis, beta oxidation and reduced oxidative 
phosphorylation66.  
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A 
 
B 
 
Figure 2. Molecular structures of palmitic and oleic acid. 
Chemical structures of the most abundant non-esterified fatty acids: A) 16-carbon saturated 
palmitic acid and B) 18-carbon monounsaturated oleic acid. Figure modified from Shah 
and Cox, 200968. 
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1.7 Effects of NEFAs on Reproduction 
Early exposure to maternal high fat diet in vivo until the 2-cell stage significantly lowers 
development of mouse embryos in vitro to the blastocyst stage from 65% to 50%69. In 
mice, when implanted in control mothers after embryo transfer, oocytes from high fat 
mothers showed malformations in the  mitotic spindle, as well as significantly more brain 
defects in mice from these high fat mothers’ blastocysts69. Additionally, increased NEFAs 
in follicular fluid are correlated with poor COC quality70. An accumulation of unfolded or 
misfolded proteins causes ER stress, which the cell attempts to alleviate by activating the 
unfolded protein response (UPR) pathway. Treatment of COCs with NEFAs resulted in 
impaired blastocyst development, however rescue by the UPR pathway inhibitor salubrinal 
identified UPR activation as a major contributor to this NEFA-dependent developmental 
decrease71.  
When Jungheim et al. cultured mouse morulae in 200 M of PA for 30 hours, they found 
that embryos exposed to PA had cell numbers that were significantly lower than embryos 
cultured in control media72. When they exposed blastocysts to PA for 30 hours and 
transferred these embryos into surrogate mothers, pups produced from PA-exposed 
blastocysts were significantly smaller than controls (termed intrauterine growth restriction, 
IUGR) and experienced catch up growth72. The literature has established a strong 
relationship between IUGR and catch up growth, insulin insensitivity, development of type 
2 diabetes and obesity in offspring73. Altogether, this information suggests that 
preimplantation development exposure to PA may have long term negative impacts on not 
only embryo development, but the adult health of offspring arising from these embryos. 
1.8 PA vs. OA: Their Effects Throughout the Body 
Although the effects of PA and OA have yet to be investigated during preimplantation 
mouse development, these NEFAs have been thoroughly investigated in other tissues. 
Interestingly, PA and OA have differential effects in many tissues. PA is implicated as 
being pro-apoptotic, while OA has been shown to have beneficial and protective effects 
against PA. For example, a recent review reported that PA is proinflammatory and induces 
endoplasmic reticulum (ER) stress74. However, the negative effects of PA can be overcome 
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by relatively lower concentrations of OA in many tissues, including hepatocytes and 
pancreatic  cells74.  
The literature shows that PA has consequences in that it reduces insulin sensitivity in 
hepatocytes 59 and skeletal muscle 75, thereby contributing to the development of type 2 
diabetes mellitus (T2DM). Conversely, OA is protective against insulin resistance and 
T2DM 74. OA protected against PA-induced insulin resistance and apoptosis in 
hepatocytes59.  PA dose-dependently increased podocyte ROS production and apoptosis, 
suggesting its contribution to podocyte loss in the kidney and subsequent development of 
diabetic nephropathy 76. When administered intraperitoneally (IP), PA causes behavioral 
abnormalities as well, such as anxiety-like symptoms in mice 77. Unpublished data that was 
collected during my undergraduate thesis (Appendix A) showed that increasing doses of 
PA displayed a concentration responsive reduction in the number of early stage mouse 
embryos reaching the blastocyst stage over the 2 days that they were in culture. 
The literature suggests that PA mediates its negative effects through a variety of 
mechanisms65,78, including alterations to membrane fluidity, ER stress, triacylglycerol 
(TAG) synthesis, lipid accumulation, mitochondrial function, ceramide synthesis, and ROS 
production (Figure 3).  
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Figure 3. Mechanisms through which palmitic acid mediates its effects. 
Upon entering the cell, palmitic acid causes lipotoxicity in many tissues, seen as ER stress, 
reactive oxygen species (ROS) production and apoptosis. This lipotoxicity is mediated 
through alterations in mitochondrial activity (beta oxidation and mitochondrial superoxide 
levels), triglyceride synthesis, ceramide levels, and at the level of toll-like receptor 4 
(TLR4). PA-associated lipotoxicity reduces cell viability and is associated with many 
pathologies.  
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1.9 PA vs. OA: Differential Effect on ER Stress Activation  
In general, PA induces ER stress and apoptosis among many cell systems including 
primary rat hepatocytes79, primary neonatal cardiomyocytes (NCMs)80, and H9C2 
cardiomyoblasts81, amongst other cell types investigated to date79,82–87.  Interestingly, PA 
and OA, the two most abundant NEFAs in the human body, have very different effects on 
tissues and cells exposed to them. PA is more apoptotic88,89, whereas OA is protective 
against PA’s effects59,90. ER stress occurs in response to an accumulation of unfolded or 
misfolded proteins in the ER. The UPR pathway is activated in an attempt to alleviate this 
stress91. If unable to establish homeostasis, the UPR results in apoptosis92. Differential 
effects of physiologically relevant doses of PA and OA on ER stress were clear in hepatoma 
cells, where PA induced ER stress and OA did not93,94. In primary NCMs, PA induced both 
ER stress and apoptosis whereas OA alone did not80. In these NCMs, OA prevented PA-
induced ER stress and apoptosis80.  
In cardiomyoblasts, OA treatment increased lipid droplet (LD) levels whereas PA 
treatment did not affect LD accumulation, visualized as BODIPY staining81. This lack of 
increase in LDs with PA treatment was not due to a lower supply of neutral lipid, as more 
PA accumulated in the cells than OA, and fatty acid oxidation was reduced with PA 
exposure81.  Thus, Akoumi et al. concluded that the reductions in LDs with PA were due 
PA storage as diacylglycerols (DAGs), whereas OA is largely stored as TAGs. Piccolis et 
al. found that PA also incorporated into lyso-phosphatidic acids, lyso-phosphatidylinositol, 
and phosphatidic acids85. Since TAGs, but not DAGs, are neutral lipids that can be stored 
in lipid droplets this suggests that PA accumulates in the ER as DAGs rather than being 
incorporated into LDs81. Accumulation of PA in the ER likely contributes to induction of 
ER stress, activation of the UPR and apoptosis should the ER stress not be relieved. In 
contrast, the Akoumi group reported that in primary NCMs, both PA and OA increased 
lipid droplet levels, visualized as BODIPY staining80. Differences in the effect of PA on 
lipid droplet levels80,81 signifies that depending on the cell type, PA has different effects on 
lipid droplet accumulation. 
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PA’s effects are broad across many different tissues, however the effect of PA and OA in 
the reproductive tract, specifically during preimplantation embryo development, has not 
been extensively investigated and defined. 
1.10 The Endoplasmic Reticulum and its Function 
The endoplasmic reticulum (ER) is a cellular organelle with a vast variety of functions. 
These include, but are not limited to, protein synthesis and processing, triglyceride 
synthesis, and lipid droplet synthesis.  
1.10.1 Protein Synthesis and Processing 
The Central Dogma defines that within a cell, DNA is transcribed into messenger RNA 
(mRNA), which is then translated by ribosomes into proteins. Ribosomes can be found 
throughout the cell, with different types of proteins being produced by ribosomes in 
different areas. For example, cytosolic proteins are translated by cytosolic ribosomes95. 
However, proteins destined to be exported or shuttled elsewhere are produced through 
translation of mRNA by membrane-bound ribosomes on the ER95. A signal sequence on 
the N-terminus of immature polypeptides targets these proteins to the ER96. After 
translation, release of the nascent polypeptide from the ribosome allows for shuttling of 
these newly synthesized proteins across the ER membrane and into the ER lumen97. Post-
translational modification of proteins occurs in the ER. This allows for production of 
mature proteins which are properly folded and capable of carrying out their unique 
functions.  
1.10.2 Triacylglyceride Synthesis 
Fatty acids (FAs), either bound to albumin or contained in lipoproteins, are found 
extracellularly. Once released, FAs enter the cell where they are conjugated to CoA98. A 
series of enzymatically catalyzed reactions in the ER allows for formation of 
diacylglycerols (DAGs), which can then form TAGs98,99. Conversion of DAG to TAG is 
the final step of TAG formation and is catalyzed by diacylglycerol acyltransferase (DGAT) 
enzymes DGAT1 and DGAT2. A review by Ahmadian et al. presented that DGAT1 and 
DGAT2 are unique from one another, with a loss of DGAT2 resulting in death soon after 
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birth in mice, whereas DGAT1 knockout mice survived and were resistant to obesity and 
insulin insensitivity99.  
1.10.3 Lipid Droplet Synthesis 
LDs are organelles found in cells throughout the body. PA and OA differentially affect LD 
accumulation. Since OA is steatotic and causes lipid accumulation, exposure to OA 
increases LD number in many cell types. LDs are made up of a phospholipid monolayer 
surrounding a neutral lipid core mainly consisting of TAGs98. LD formation occurs in the 
ER with perilipin proteins stabilizing the LD as it forms100. As TAGs accumulate within 
the ER, the lipid droplet increases in size and eventually buds off of the ER and into the 
cytosol101. 
1.10.4 The ER Stress Response 
The UPR is a conserved pathway in mammals which is activated in response to 
endoplasmic reticulum (ER) stress91,92. ER stress occurs when there is an accumulation of 
unfolded or misfolded proteins in the ER. This activates the ER stress pathway, of which 
the UPR is a part. Other factors such as interruptions in calcium homeostasis can also 
induce ER stress and the UPR102. When a cell undergoes ER stress, the UPR is activated 
in an attempt to alleviate the stress on the ER. The UPR does this by91,92:  
1) Increasing ER-associated protein degradation (ERAD).  
2) Decreasing protein synthesis.  
3) Producing chaperones to aid in protein folding. 
If unable to alleviate the stress and reestablish homeostasis, cells experiencing chronic ER 
stress will undergo cell death: either through autophagy, senescence or apoptosis103. Thus, 
lipotoxicity via UPR signaling has been associated with many diseases104. 
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Figure 4. The unfolded protein response. 
ER stress due to misfolded/unfolded proteins activates the unfolded protein response 
(UPR). With ER stress BiP dissociates from the transmembrane protein transducers of the 
UPR which make up the 3 different arms: 1) PRK-like ER kinase (PERK, blue), 2) inositol-
requiring enzyme 1 (IRE1, green), or 3) activating transcription factor 6 (ATF6, purple), 
which activates the UPR. Activation of the PERK arm causes reduced translation, and 
increases ATF3, ATF4, growth arrest and DNA damage-inducible protein (GADD34), and 
C/EBP homologous protein (CHOP) downstream of EIF2. Activation of the IRE1 arm 
results in X-box binding protein 1 (XBP1) splicing and jun N-terminal kinases (JNK) 
activation. Altogether, activation of the three arms of the UPR acts to alleviate ER stress 
by 1) decreasing protein load by reducing translation 2) increasing ER-associated protein 
degradation (ERAD), and 3) facilitating protein folding through increasing chaperone 
production. If unable to alleviate ER stress, the UPR results in apoptosis.  
Figure adapted from Flamment et al92. and Schroder and Kaufman91. 
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The UPR (Figure 4) has three different arms, each of which is regulated by a 
transmembrane protein on the ER membrane: 1) PRK-like ER kinase (PERK), 2) inositol-
requiring enzyme 1 (IRE1), or 3) activating transcription factor (ATF) 692. 
Immunoglobulin heavy-chain binding protein (BiP), encoded by the gene HSPA5, is a 
chaperone found in the ER92,105 which is essential for preimplantation embryo 
development106. BiP acts as a chaperone, stabilizing newly produced proteins as they are 
brought into the ER prior to further processing, as well as when exporting unwanted 
proteins out of the ER for degradation107. When there is no ER stress, BiP binds to and 
inhibits PERK, IRE1, and ATF691,92. Upon induction of ER stress, BiP dissociates from 
these transmembrane UPR transducers, removing its inhibitory effect, and interacts with 
irregular proteins in the ER to promote correct folding91,92. When unbound from BiP, 
PERK, IRE1, and ATF6 are in an active state and each of the three arms of the UPR are 
activated92. 
Once unbound from BiP, PERK monomers form a dimer and autophosphorylation occurs. 
The phosphorylated PERK dimer has kinase activity, allowing it to phosphorylate 
downstream components such as eukaryotic initiation factor 2 alpha (EIF2). 
Phosphorylated EIF2 causes a decrease in translation of mRNA into protein, and 
increases translation of activating transcription factor 4 (ATF4)92. ATF4 increases 
transcription of growth arrest and DNA damage-inducible protein (GADD34), activating 
transcription factor 3, and C/EBP homologous protein (CHOP)91,92, with ATF3 further 
increasing the abundance of GADD34 and CHOP proteins91. CHOP promotes apoptosis, 
in part, by increasing GADD34, a regulatory subunit of protein phosphatase 1 (PP1)91,92. 
Activation of PP1 results in dephosphorylation of EIF2, causing an increase in translation 
of mRNAs and ER stress108.     
When unbound from BiP, IRE1 forms a dimer, and autophosphorylation occurs, activating 
its endoribonuclease activity. This allows IRE1 to cleave X-box binding protein 1 (XBP1) 
to form XBP1s. XBP1s acts as a transcription factor and increases transcription of 
chaperones and components of ERAD. Activation of the IRE1 arm of the UPR promotes 
apoptosis92,109 through activation of jun N-terminal kinases (JNKs), which increase 
transcription of pro-apoptotic genes109. In an attempt to prevent more proteins from being 
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synthesized in the ER, IRE1 directly degrades mRNAs in the ER through a process called 
regulated IRE1-dependent decay (RIDD)92.  
Under ER stress, ATF6 is unbound from BiP and is transported to the Golgi apparatus 
where it is cleaved. The cleaved protein then causes an increase in transcription of protein 
chaperones and ERAD machinery.  
1.11 PA vs. OA: Differential Effect on Mitochondrial ROS 
production 
Another organelle which is differentially affected by PA an OA is the mitochondrion. 
Fayezi et al. suggested that OA aids in preimplantation embryo development by reducing 
oxidative stress and altering energy production110, both of which occur in the mitochondria. 
The mitochondrion is often referred to as the powerhouse of the cell and is a key site for 
metabolism and energy production. Large amounts of ATP are produced here by the citric 
acid cycle (2 ATP/glucose molecule) and electron transport chain (ETC, 34 ATP/glucose 
molecule). In the ETC, electrons are passed through the chain to create a proton gradient 
that powers ATP synthase. Oxygen acts as the final electron acceptor and water is 
produced, however as a result of ETC activity, a portion of the electrons contribute to 
producing superoxide111. Elevated mitochondrial ROS levels are associated with aging and 
disease112.   
PA and OA have different effects on mitochondrial ROS production. In cardiomyocytes 
PA, but not OA, causes an increase in mitochondrial ROS levels113. In skeletal myotubes 
OA prevented PA-induced atrophy which was associated with a decrease in mitochondrial 
superoxide production114. This suggests that increasing ROS levels may be a mechanism 
through which PA mediates its effects or that mitochondrial superoxide accumulation is a 
result of PA-induced mitochondrial dysfunction.  
1.12 Rationale  
Investigating the effects of NEFAs on preimplantation embryos in vitro is required and will 
expand our understanding of women’s reproductive biology two-fold. First, understanding 
the effects of individual NEFAs, PA and OA, in isolation and in combination gives us 
19 
 
insight into understanding the mechanisms affected by NEFAs during mammalian 
preimplantation embryo development in general. As presented earlier, PA and OA have 
well established and different effects in other cell types, and the protective effect of OA in 
preimplantation mouse embryos had yet to be investigated prior to this study. This study 
provides us with a better understanding of the mechanisms altered with the high-fat 
environment in an obese mother (such as ER stress, mitochondrial superoxide and lipid 
droplet accumulation), which may affect preimplantation development in vivo. Second, 
with ARTs, production of the greatest number of viable, developmentally competent 
embryos is essential in order to minimize the emotional, physical, and financial cost of 
treatment. Investigating ways in which modification of the in vitro culture environment can 
alleviate deleterious effects of exposure to certain NEFAs will promote their translation to 
the fertility clinic to optimize culture media and produce the greatest number of high-
quality embryos for transfer and fertility success. This study presents critical early data that 
initiates this process of translatable outcomes that will result in eventual optimization of 
human in vitro embryo culture media, and especially so, for the obese patient.  
1.12.1 Objectives and Hypotheses 
Previous research from my undergraduate thesis discovered that PA reduces the proportion 
of mouse embryos that develop from the two-cell stage to the blastocyst stage. 
Interestingly, the literature has shown in other tissues that the negative effects of PA can 
be prevented by OA exposure59,63,74,90,115–119.  
The overall objective of my MSc thesis research is to investigate whether impaired 
development seen with PA exposure alone can be prevented by OA co-treatment. 
Additionally, I aimed to identify and investigate the mechanisms underlying these effects 
during mouse preimplantation development in vitro.  
1.12.2 Specific Aims 
1. Define the effects of OA treatment on mouse preimplantation development to the 
blastocyst stage relative to non-NEFA media. This will be investigated by assessing 
developmental progression of embryos after exposure of 2-cell embryos to OA for 
46 hours.  
20 
 
2. Determine the effects of co-culture of embryos in both PA and OA on mouse 
preimplantation development to the blastocyst stage. This will be investigated by 
assessing developmental stage of embryos after exposure of 2-cell embryos to 100 
l PA alone or in combination with either 50, 100 or 250 M OA for 46 hours. 
3. Investigate the mechanisms underlying the effects of PA and OA co-culture, 
including ER stress, lipid droplet abundance, and mitochondrial ROS production.  
1.12.3 General Hypothesis 
OA exposure from the two-cell stage onward will attenuate PA-induced reductions in the 
proportion of mouse embryos developing to the blastocyst stage. 
1.12.4 Specific Hypotheses 
 
1. In contrast to PA reducing embryos’ capacities to develop to the blastocyst stage, 
mouse embryos exposed to OA will develop to the blastocyst stage at similar 
proportions to control embryos. 
 
2. OA will attenuate PA-induced reductions in the proportion of embryos developing 
to the blastocyst stage. 
 
3. PA will elevate ER stress pathway constituent mRNA levels and mitochondrial 
superoxide production, both of which will be reduced when OA co-treatment with 
PA occurs.  
 
4. Culture of embryos in PA or OA results in altered lipid handling – with OA 
resulting in increased lipid droplet accumulation. 
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Chapter 2  
2 Materials and methods 
2.1 Animal Source and Ethics Approval 
All experiments were performed using CD-1 mice from Charles River Laboratories (Saint-
Constant, QC). All mice were handled according to the Canadian Council on Animal Care 
and Western University’s Animal Care and Use Policies (protocol #: 2018-075 to Dr. 
Andrew J. Watson). Mice were housed using conventional housing with a 12-hour 
light/dark cycle and access to food ad libitum. Documentation of ethics approval can be 
found in Appendix B. 
2.2 Mouse Superovulation and Mating 
Four to six-week-old female mice received intraperitoneal (IP) injections of 7.5 
international units (IU) of pregnant mare’s serum gonadotropin (PMSG, Merck Animal 
Health, Canada) to stimulate follicular recruitment. 48 hours later, these same females were 
IP injected with 7.5 IU human chorionic gonadotropin (hCG, Merck Animal Health, 
Canada) to stimulate ovulation. Immediately after hCG injection, each female was placed 
in a cage with a single male CD-1 mouse for natural mating overnight. Injection and 
subsequent placement of females with males were performed between 4 pm and 6 pm for 
all experiments. The following morning, vaginas of the female mice were visually checked 
for a seminal plug, which indicated that successful mating had occurred. Unmated females 
were marked, and all of the superovulated females were placed in their original housing 
cage. Forty-six hours post-injection (hpi) of hCG, all female mice were sacrificed through 
CO2 asphyxiation, and those with confirmed seminal plugs were dissected to isolate the 
oviducts. M2 flushing medium (Sigma Aldrich, Canada) was warmed to 37oC, drops of 
this media were added to a dish which was placed on a flask of water heated to 37oC under 
a heating lamp. This system was used during the process of isolating the embryos to 
maintain temperature of the culture environment. Under a light microscope, each oviduct 
was flushed using a syringe, needle (30Gx1/2), and warmed M2 flushing medium. Two 
cell embryos were washed thrice in 50 l drops of potassium simplex optimization media 
with amino acids (KSOMaa Evolve, Zenith Biotech, Canada) containing 1 mg/ml 
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essentially fatty acid free bovine serum albumin (BSA, Sigma-Aldrich, Canada). After 
washing, these embryos were distributed amongst the given treatment groups for that 
experiment and cultured in 20 l drops at a density of 1 embryo per microliter. For 
example, 40 embryos were distributed amongst two drops to maintain the embryo to 
medium ratio. Embryos were cultured for 46 hours, to what is expected to be the blastocyst 
stage, after which various analyses were performed. 
2.3 NEFA Preparation and Embryo Culture 
Essentially FFA-free BSA was added to PBS and dissolved overnight to create a 20% BSA 
solution. This solution was filter sterilized and used downstream for conjugation to palmitic 
acid (PA, Sigma-Aldrich, Canada) or oleic acid (OA, Sigma-Aldrich, Canada). Stock PA 
and OA solutions were prepared by solubilizing each fat in RNAase-free water using 
NaOH at 70oC to create a 20 mM solution.  
This stock sample was conjugated in a 2:1 molar ratio to BSA to create a final 500 M 
NEFA solution that was stored at 4oC. Experiments were performed where 2 cell embryos 
were cultured in NEFA conjugated 2:1 to BSA in KSOMaa. 
Experiment 1: Effects of OA exposure on preimplantation embryo development 
Experiment 1 defined the concentration response effects of OA treatment alone (50, 100, 
250, and 500 M OA) on mouse preimplantation development. Controls for BSA content 
of 1 mg/ml or 1.5% BSA in KSOMaa medium were used to test whether BSA 
concentration altered embryo development. 
Experiment 2: Effects of OA exposure on PA-induced effects on preimplantation embryo 
development 
Experiment 2 defined the concentration response effects of OA and PA in combination on 
preimplantation development.  Experiment 2 treatments included: BSA control, 100 M 
PA alone, or 100 M PA in combination with either 50, 100 or 250 M OA in KSOMaa. 
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2.3.1 Embryo Culture 
The BSA content was controlled for between treatments using 1.5% BSA in KSOMaa, 
which was prepared from the original 20% BSA solution.  For all treatment experiments, 
20 2-cell embryos were placed into 20 l drops of the appropriate treatment medium 
covered by embryo-grade mineral oil (Zenith Biotech, Canada).  Embryos were cultured 
under a 5% CO2, 5% O2, and 90% N2 atmosphere at 37
oC for 46 hours to assess progression 
to the blastocyst stage. The percentage of embryos at each stage of preimplantation 
development following 46 hours of culture was determined prior to embryo collection and 
processing for transcript abundance analysis, or lipid droplet assessment and mitochondrial 
superoxide detection using confocal microscopy.  
2.4 Developmental Stage Analysis 
At the end of the culture period (46 hours), embryos were examined under a light 
microscope. The number of embryos at each stage of pre-implantation development was 
recorded. Embryos were classified as either a blastocyst, morula, 8-cell, 4-cell, 2-cell or 
degenerated embryo. Two-cell, 4-cell and 8-cell embryos exhibited 2, 4, and 8 distinct 
blastomeres, respectively. Morulae were defined as embryos where distinct blastomeres 
could not be identified or counted but no visible fluid-filled cavity was apparent. 
Blastocysts were defined as any embryo with a visible fluid-filled cavity. Degenerated 
embryos were those with visibly degraded blastomeres (often with a compromised cell 
membrane and are dark and granular in appearance). For further analyses, only embryos 
that showed development to beyond the 4-cell stage and did not have degraded blastomeres 
were assessed. After developmental analysis, embryos were either exposed to a live stain 
and visualized, snap frozen at -80oC for RNA extraction, or fixed for future staining and 
confocal microscopy.  
2.5 RNA Extraction and Reverse transcription 
The ARCTURUS PicoPure RNA Isolation Kit (Life Technologies, Burlington, ON) was 
used per the manufacturer protocol to extract total RNA from preimplantation mouse 
embryos. Exogenous luciferase mRNA (0.0025 pg/embryo, Promega, USA) was added for 
use as a reference gene when analyzing mRNA quantities using the delta delta cycle 
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threshold (2-Ct) method. To eliminate genomic DNA, DNase 1 (RNA free DNase kit, 
Qiagen, Louisville, KY) was added in an additional step. VILO cDNA Synthesis Kit 
(Invitrogen, Burlington, ON) was used according to the manufacturer protocol to reverse 
transcribe the extracted RNA into cDNA. cDNA was diluted to 1 embryo/l using PCR-
grade water.  
2.6 Transcript Detection through Polymerase Chain 
Reaction (PCR) 
To confirm the effectiveness/quality of cDNA synthesis, PCR was performed for H2A and 
luciferase. Each reaction included 2.5 l of 10X PCR buffer, 0.75 l MgCl2, 0.5 l dNTPs, 
0.1 l each of the forward and reverse primer, 0.2 l Taq Polymerase, and 19.85 l RNase-
free water. The cycling conditions for both H2A and luciferase were: 94oC for 2 min, 
followed by 44 cycles of 94oC for 30 seconds, 61oC (H2A) or 59oC (luciferase) for 30 
seconds, 72oC for 1 minute, and a last step of 72oC for 10 minutes. PCR products were run 
on a 2% agarose gel for H2A/luciferase with ethidium bromide in TAE running buffer at 
100V for one hour, after which the gel was imaged.  
For XBP1 mRNA transcript detection, cycling conditions were: 94oC for 2 min, followed 
by 45 cycles of 94oC for 30 seconds, 61oC for 30 seconds, 72oC for 1 minute, and a last 
step of 72oC for 10 minutes. XBP1 PCR products were run on a 4% agarose gel with TBE 
running buffer at 60 V for 3 hours. Positive controls contained cDNA from embryos that 
were treated with the potent and reliable ER stress inducer tunicamyin120 while negative 
controls included RNase-free water in place of cDNA.  Splicing of XBP1 was quantified 
using ImageJ software on three biological replicates. 
2.7 Quantitative PCR (qPCR) for assessment of relative 
transcript levels 
Quantitative PCR was performed using Taqman primer probes (Invitrogen, Canada) for 
target genes in a 384-well plate. Based off of the total number of wells needed in an 
experiment, a mastermix (MM) was prepared. For each well, 20 l of stock MM was 
prepared. The MM was made up of TaqMan Gene Expression Mastermix (volume = 0.5 x 
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total volume(V)), TaqMan primer probe (volume=0.05xV), and RNase-free water (volume 
= 0.4 x V). Once the three components were combined, the mixture was vortexed, 62.7 l 
of MM for each treatment group were aliquoted into Eppendorf tubes, to which 3.3 l 
(equivalent to 1 embryo/l) of cDNA were added. This mixture of master mix and cDNA 
was vortexed, and 20 l was added in triplicate wells to the PCR plate. For each gene, a 
negative non-transcript control was included, where RNase-free water replaced the cDNA. 
A film was then used to seal the wells, and the plate was centrifuged at 1800 rpm for 2 
minutes. Using a BioRad CFX384 TouchTM Real-Time PCR Detection System, qPCR was 
run according to the following conditions: 5 minutes at 95oC (AmpliTaq GOLD DNA 
polymerase activation step), followed by 50 cycles of 15 seconds at 95oC (denaturation) 
and 1 minute at 60oC (annealing and extension). To assess ER stress, primer probes for 
ATF3 (Mm00476032_m1), CHOP (Mm01135937_g1 Ddit3), and ATF6 
(Mm01295317_m1 Atf6) were used. In assessing triacylglyceride synthesis, DGAT1 
(Mm00515643_m1 Dgat1), and DGAT2 (Mm00499536_m1) transcripts were assessed. 
Three biological replicates were assessed for each gene.  
2.8 Confocal Microscopy 
Confocal microscopy was performed using the 10x objective lens on a Zeiss LSM800 
microscope. Z-stacks were imaged in 5 m slices. Images were processed using FIJI and 
Ilastik software. When imaging, all treatment groups within an experiment were visualized 
using the same laser intensity and settings.  
2.9 BODIPY staining to assess embryo lipid droplet 
accumulation 
After the 46-hour culture treatment period, embryos from each treatment and control were 
placed in 2% paraformaldehyde for 30 minutes for fixing. They were then washed thrice 
in PHEM and placed at 4oC. BODIPY 493/503 (Thermo Fisher, USA) was solubilized in 
DMSO to a concentration of 2.5 mg/ml to create a stock solution, and an aliquot was diluted 
to 20 g/ml using KSOMaa medium. Embryos from all treatment groups, except the 
negative control, were placed in 20 l drops of BODIPY solution covered in embryo-grade 
mineral oil for 1 hour at room temperature. This concentration was based off of previously 
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published literature121. Embryos were then washed thrice in PBS and added to 10 l drops 
of PBS covered in mineral oil in a glass-bottom dish. An independent group of embryos 
exposed to OA at varying concentrations were used to set the laser intensity (Alexa Fluor 
488). Embryos were imaged using confocal microscopy at 10 times magnification. Within 
a group each embryo was considered to be a biological replicate (N=12-18), such that the 
fluorescence of a single embryo was quantified and contributed to determining mean 
fluorescence within a treatment using Ilastik software.  
2.10 MitoSox Superoxide Stain 
Staining live embryos for mitochondrial superoxide was performed using the same 
methods outlined in a recent publication from our lab122. MitoSox Red mitochondrial 
superoxide indicator (Life Technologies, USA) was solubilized in DMSO and diluted using 
KSOMaa to a concentration of 5M. Culture dishes were prepared with 20 l drops of this 
medium covered in embryo-grade mineral oil. Live embryos (N=19-28) were incubated in 
this solution for 1 hour at 37oC 5% O2, 5% CO2 and 90% N2. A no-BODIPY negative 
control was also included. Embryos were then washed thrice in KSOMaa and added to 10 
l drops of KSOMaa in a glass-bottom dish for imaging through confocal microscopy at 
10 times magnification. An independent group of embryos exposed to 100 M PA 
treatment were used to set the confocal laser intensity (Alexa Fluor 568). Embryos were 
imaged using confocal microscopy at 10x magnification.  
2.11 Statistical analyses 
GraphPad PRISM 8 was employed to perform statistical analyses. Experiments were 
performed on a minimum of three biological replicates. For imaging studies, a biological 
replicate was defined as a single embryo within a treatment. However, for assessments of 
developmental stage and mRNA abundance through qPCR, a biological replicate was 
classified as a single pool of embryos within a treatment group. The number of blastocysts 
within experiment 1 and experiment 2 were analyzed using a one-way analysis of variance 
(ANOVA) text, and means were compared to one another by an ad-hoc Tukey’s multiple 
comparisons test. The same statistical analyses were used when analyzing the number of 
embryos arrested at different stages of development with the NEFA treatments. Using cycle 
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threshold values from qRT-PCR, relative amounts of mRNA were quantified using the 
delta delta cycle threshold (2-Ct) method followed by One-Way ANOVA and Tukey’s 
multiple comparisons tests. P values less than or equal to 0.05 were considered statistically 
significant. 
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Chapter 3  
3 Results 
3.1 Effects of PA and OA on preimplantation embryo 
developmental stage 
My preliminary unpublished data (4th year thesis; Appendix A) demonstrated that PA 
significantly reduces (P<0.05) mouse embryo development to the blastocyst stage in a 
concentration responsive manner, beginning at a 50 M concentration. Outcomes from the 
first experiment suggest differential effects of PA and OA. Representative images of OA 
treated embryos and non-treated controls are shown in Figure 5. When compared to PA 
alone, there were morphological differences in embryos that were exposed to OA alone 
(Figure 5) or in combination with PA (Figure 6). Embryos exposed to only PA displayed 
some fragmentation and blastomeres that were unequal in size. However, embryos exposed 
to OA alone or in combination with PA did not display these characteristics.  
Additionally, PA and OA differentially affected blastocyst development (Figure 7). At all 
concentrations (0-500 M) of OA treatment from the 2-cell stage onward, blastocyst 
(Figure 7A), morula (Figure 8A), 8-cell (Figure 9A), and 2 to 4-cell (Figure 10A) 
percentages did not differ from untreated controls (P>0.05, N=3). However, 250 and 500 
M OA treatment did result in a greater number of embryos with degraded blastomeres 
(P=0.01, N=3, Figure 10A) than controls. Controls for BSA content (BSA=1.5% BSA, 0=1 
mg/ml BSA, P>0.05, N=3, Figure 7A) showed that BSA content of the NEFA-containing 
media did not affect embryo development to the blastocyst stage.  
To assess the effect of OA exposure in embryos exposed to PA, embryos were cultured in 
either control media, 100 M PA media alone, or PA in combination with 50, 100 or 250 
M OA. PA alone caused a significant 6.3-fold reduction in development to the blastocyst 
stage relative to controls (P<0.0001, N=3, Figure 7B), with embryos arresting in 
development before the morula stage (P<0.05, N=3, Figures 9-11). The proportion of 
embryos arresting at the morula stage did not differ between treatments (P>0.05, N=3, 
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Figure 8N). The PA-induced decreases in blastocyst development were prevented by OA 
exposure at 50-250 M concentrations (P<0.05, N=3, Figure 6A).  
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Figure 5. Phase contrast representative images of embryos cultured in oleic acid 
(OA). 
Embryos cultured from the 2-cell stage for 46 hours in A) a 1.5% BSA control, B) 1 mg/ml 
BSA control, C) 50 M OA, D) 100 M OA, E) 250 M OA, F) 500 M OA. Images 
were taken using a phase contrast microscope and 20x objective lens. Arrows show 
representative blastocysts. Scale bars signify 100 m.  
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Figure 6. Representative phase contrast images of mouse embryos treated with 
palmitic acid (PA) and oleic acid (OA). 
Embryos cultured from the 2-cell stage for 46 hours in A) control, B) 100 M PA alone or 
in combination with C) 50 M OA, D) 100 M OA or E) 250 M OA. Images were taken 
using a phase contrast microscope and 20x objective lens. Asterisks signify oil drops which 
had adhered to the dish with embryo handling. Scale bars signify 50 m.  
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Development to all stages of preimplantation development was no different from controls 
when OA was included in PA embryo culture media (P>0.05, N=3, Figures 7-11).  
Exposure to 100 M PA significantly reduced the proportion of blastocysts relative to 
controls (N=13, P<0.0001, Tukey’s multiple comparisons test, Figure 7B). Co-culture of 
2-cell embryos in 100 M PA with either 50, 100 or 250 M OA (N=10-12) attenuated 
this PA-induced decrease such that embryos exposed to both NEFAs displayed blastocyst 
development similar to controls (P>0.05, Tukey’s multiple comparisons test). Embryos co-
cultured with PA and OA showed significantly more blastocysts after culture than PA-only 
embryos when 50 (P=0.005), 100 (P=0.0001) or 250 (P<0.0001) M OA was included. 
Exposure to 100 M palmitic acid (PA) did not affect the number of morulae relative to 
controls (N=13, P=0.99, Tukey’s multiple comparisons test, Figure 8B). Co-culture of 2-
cell embryos in 100 M PA with either 50, 100 or 250 M OA (N=10-12) resulted in a 
proportion of embryos being at the morula stage that was not significantly different from 
controls (Figure 8B, P>0.05, Tukey’s multiple comparisons test). 
Mouse embryos cultured for 46 hours from the 2-cell stage arrested at the 8-cell stage at 
differential proportions with NEFA treatment. Increasing oleic acid concentrations of 0-
500 M did not affect the number of 8-cell embryos after 46-hour culture (Figure 9A, 
N=3, P=0.35, One-Way ANOVA). Exposure to 100 M palmitic acid significantly 
increased the number of 8-cells relative to controls (N=13, P<0.0001, Tukey’s multiple 
comparisons test, Figure 9B). Co-culture of 2-cell embryos in 100 M PA with either 50, 
100 or 250 M OA (N=10-12) attenuated this PA-induced increase such that embryos 
exposed to both NEFAs displayed 8-cell development similar to controls (P>0.05, Tukey’s 
multiple comparisons test, Figure 9B). Embryos co-cultured with PA and OA showed 
significantly less 8-cells after culture than PA-only embryos when 50 (P<0.0001), 100 
(P<0.0001) or 250 (P<0.0001) M OA was included.  
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Figure 7. Blastocyst preimplantation embryo percentage after 46-hour culture. 
The percentage of blastocysts after 46-hour culture in A) BSA control (1.5% BSA in 
KSOM), control (1 mg/ml BSA in KSOM) or increasing concentrations of OA (N=3, 
P=0.37, One-Way ANOVA) or B) co-culture in PA and OA (N=10-13, P<0.0001, One-
Way ANOVA). Bars represent the mean percentage of embryos at the blastocyst stage + 
standard deviation (SD). Bars with different letters are statistically significant according to 
Tukey’s multiple comparisons test.  
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Figure 8. Morula preimplantation embryo percentage after 46-hour culture. 
The percentage of mouse morulae after 46-hour culture from the 2-cell stage in A) 
increasing concentrations of OA (N=3, P=0.64, One-Way ANOVA) or B) co-culture in PA 
and OA (N=10-13, P=0.33, One-Way ANOVA). Bars represent the mean percentage of 
embryos at the morula stage + SD. Bars with different letters are statistically significant 
according to Tukey’s multiple comparisons test.  
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Figure 9. Eight-cell preimplantation embryo percentage after 46-hour culture. 
The percentage of 8-cells after 46-hour culture in A) increasing concentrations of OA 
(N=3, P=0.35, One-Way ANOVA) or B) co-culture in PA and OA (N=10-13, P<0.0001, 
One-Way ANOVA). Bars represent the mean percentage of embryos at the 8-cell stage + 
SD. Bars with different letters are statistically significant according to Tukey’s multiple 
comparisons test.  
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Exposure to 100 M palmitic acid (PA) significantly increased the number of 2 to 4-cells 
relative to controls at 46 h post culture (Figure 10B; N=13, P<0.0002, Tukey’s multiple 
comparisons test). Co-culture of 2-cell embryos in 100 M PA with either 50, 100 or 250 
M OA (N=10-12) attenuated this PA-induced increase such that embryos exposed to both 
NEFAs displayed 2 to 4-cell proportions similar to controls (P>0.05, Tukey’s multiple 
comparisons test). Embryos co-cultured with PA and OA showed significantly less 2 to 4-
cells after culture than PA-only embryos when 50 (P<0.0008), 100 (P<0.0006) or 250 
(P<0.0087) M OA was included.  
Exposure to 100 M PA significantly increased the number of embryos with degraded 
blastomeres relative to controls (N=13, P<0.0001, Tukey’s multiple comparisons test, 
Figure 11B). Co-culture of 2-cell embryos in 100 M PA with either 50, 100 or 250 M 
OA (N=10-12) attenuated this PA-induced increase such that embryos exposed to both 
NEFAs had similar percentages of embryos with degraded blastomeres relative to controls 
(P>0.05, Tukey’s multiple comparisons test). Embryos co-cultured with PA and OA 
showed significantly less embryos with degraded blastomeres after culture than PA-only 
embryos when 50 (P=0.018), 100 (P=0.0003) or 250 (P=0.0001) M OA was included.  
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Figure 10. Two to four-cell preimplantation embryo percentage after 46-hour 
culture. 
The percentage of 2 to 4-cells after 46-hour culture in A) increasing concentrations of OA 
(N=3, P=0.69, One-Way ANOVA) or B) co-culture in PA and OA (N=10-13, P<0.0001, 
One-Way ANOVA). Bars represent the mean percentage of embryos at the 2 to 4-cell stage 
+ SD. Bars with different letters are statistically significant according to Tukey’s multiple 
comparisons test.  
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Figure 11. Percentage of embryos with degraded blastomeres after 46-hour culture. 
The percentage of 2 to 4-cells after 46-hour culture in A) increasing concentrations of OA 
(N=3, P=0.01, One-Way ANOVA) or B) co-culture in PA and OA (N=10-13, P<0.0001, 
One-Way ANOVA). Bars represent the mean percentage of embryos at the 2 to 4-cell stage 
+ SD. Bars with different letters are statistically significant according to Tukey’s multiple 
comparisons test.  
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3.2 Effects of OA and PA on ER stress activation 
From my preimplantation development assessments, OA treatment clearly exerts a 
protective influence against PA’s negative effects on blastocyst development. My 
subsequent studies initiated an investigation into the mechanisms underlying this 
differential response to PA and OA treatment on mouse preimplantation development by 
characterizing their treatment effects on ER stress pathway constituent mRNA levels. In 
OA-treated embryos, ATF3 and CHOP mRNA levels were not significantly affected by 
treatment (Figure 12). However, in embryos treated with 100 M PA alone, ATF3 
transcript abundance was over 15-fold that of control levels, and CHOP transcript 
abundance approached 5-fold greater levels than controls (Figure 13). This significant 
increase (P<0.05) in mRNA of CHOP and ATF3, both of which are in the PERK arm of 
the UPR suggests that this arm is likely activated following PA treatment at 100 M from 
the 2-cell stage onward. When OA was also included in the embryo culture medium, this 
PA-induced effect on CHOP and ATF3 mRNA levels was not observed (Figure 13), 
suggesting that OA treatment protects against PA-induced activation of the UPR. ATF6 
contributes to ER stress development under its own distinct pathway for that of the PERK 
pathway. Importantly, its transcript abundance was not significantly affected by PA 
treatment alone or in combination with OA (P>0.05, N=3), suggesting that this arm of the 
UPR is not influenced by NEFA exposure during mouse preimplantation development. 
I next investigated the influence of NEFA treatment on the IRE1 arm of the UPR by 
characterizing the effects of PA treatment alone or in combination with OA on the relative 
abundance of spliced and unspliced transcripts encoding XBP1. XBP1 is downstream of 
IRE1 pathway activation. Its activation is dependent upon transcript splicing, with spliced 
transcript representing activated XBP1 that serves as a nuclear transcription factor upon 
activation of the ER stress response. Treatment with 100 M PA resulted in both a distinct 
and quantitively significant (P<0.05, N=3) increase in XBP1 mRNA splicing (Figure 14A-
C) relative to controls. Importantly, XBP1 splicing was significantly reduced (P>0.05, 
N=3) with OA compared to embryos treated with PA only (Figure 14).  
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Figure 12. ER stress response relative transcript abundance with OA exposure. 
Unfolded protein response (UPR) transcript abundance in 2-cell mouse embryos cultured 
in vitro for 46 hours with OA (P>0.05, N=3, One-Way ANOVA). Abundance of A) 
activating transcription factor 3 (ATF3) and B) C/EBP homologous protein (CHOP) in 50, 
100, 250 or 500 M OA treatment groups. Bars represent mean fold-change in mRNA 
abundance relative to the control + SD.  
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Figure 13. ER stress response transcript abundance with OA and PA co-treatment. 
mRNA abundance after 46-hour exposure of 2-cell mouse embryos to PA alone or in 
combination with OA. Relative transcript levels of A) activating transcription factor 3 (A, 
ATF3, P=0.0001, N=3, One-Way ANOVA), B) CHOP (B, P=0.0007, N=3, One-Way 
ANOVA) and C) activating transcription factor 6 (ATF6). ATF6 transcript abundance was 
not affected (C, P=0.13, N=3, One-Way ANOVA) by NEFA exposure. Bars represent 
mean fold-change in mRNA abundance relative to the control + SD.  Bars with different 
letters are statistically significant according to Tukey’s multiple comparisons test.  
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Figure 14. XBP1 splicing with embryo culture in PA and OA.  
PCR amplified transcripts encoding XBP1 from embryos exposed to PA alone or in 
combination with OA. A-C represent three biological replicates of XBP1 transcripts on a 
4% agarose gel. D) Quantified percentage of spliced XBP1 (XBP1s, N=3, P<0.0001, One-
Way ANOVA). A no-cDNA negative control (-) and tunicamycin-treated embryo positive 
control (+) were included. Bars represent mean percentage of spliced XBP1 + SD.  Bars 
with different letters are statistically significant according to Tukey’s multiple comparisons 
test.  
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3.3 Effects of OA and PA on lipid droplet abundance 
Thus, NEFA treatment, especially PA treatment appears to activate two arms of the ER 
stress pathway in preimplantation mouse embryos and this activation in both arms is 
rescued by OA treatment. Given that LD production occurs in the ER, I sought out to 
investigate the influence of NEFA treatment on lipid droplet accumulation in mouse 
preimplantation embryos. Relative to embryos exposed to control media, OA treatment 
alone significantly increased (P<0.05, N=12, Figure 15B) embryos’ lipid droplet (LD) 
content. However, PA treatment alone did not affect (P>0.05, N=18, Figure 15C) LD 
content. Inclusion of OA in a combined 50 M OA and 100 M PA treatment medium 
resulted in lipid droplet levels that were not significantly changed from the PA-only or 
control group (N=13, P>0.05, Figure 15D). However, OA concentrations of 100 and 250 
M significantly increased lipid droplet levels to 16 and 18 times greater than controls, 
respectively (Figure 16A). This dramatically higher LD accumulation with higher OA 
concentrations was a peculiar finding. This further supports that preimplantation mouse 
embryos respond very differently to PA and OA, with the NEFA concentrations and ratios 
having a drastic effect on LD accumulation. Higher magnification views of individual 
blastocysts reveal these differences in lipid droplet number and size across treatment 
groups (Figure 16B-E).  
To investigate whether these changes in lipid droplet abundance may be accompanied by 
a treatment-induced increase in triacylglyceride synthetic enzyme gene expression, I 
characterized the relative levels of DGAT1 and DGAT2 mRNAs in embryos derived from 
all 4 experimental treatment groups. As can be seen in Figure 17, DGAT1 and DGAT2 
transcript abundance was not significantly affected by PA treatment alone or in 
combination with OA (P>0.05, N=3). There was a marked trend for decreased DGAT2 
mRNA abundance following PA treatment alone, and this was not observed when OA was 
included in the culture medium. However, due to variability observed between 
experimental replicates, this difference was not statistically significant (P=0.08).  
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Figure 15. BODIPY fluorescence with PA and OA exposure. 
Confocal images of preimplantation embryos after culture in NEFAs, fixation, and 
BODIPY 493/503 staining. A) Light images of embryos. B) Fluorescent images of 
BODIPY staining. Media noted as lowercase letters were a) control embryos, b) 100 M 
OA, c) 100 M PA, d) 50 M OA with 100 M PA, e) 100 M OA with 100 M PA, and 
f) 250 M OA with 100 M PA. Images were taken using a confocal microscope, 10x 
objective lens and Alexa Fluor 488 laser. Scale bars signify 100 m. 
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Figure 16. Quantified lipid droplet abundance. 
A) Quantified BODIPY 493/503 fluorescence in embryos cultured from the 2-cell stage 
for 46 hours in PA or OA alone or in combination (N=12-18, P<0.0001, One-Way 
ANOVA). Bars represent mean BODIPY 493/503 fluorescence per embryo + standard 
error (SE). Data is presented in fluorescence units with background fluorescence 
subtracted. Bars with different letters are statistically significant according to Tukey’s 
multiple comparisons test. Representative higher magnification views of BODIPY LD 
fluorescence in PA (100 M) and OA treated at 100 M (B) and 250 M (D) and their 
corresponding light microscope (C, E) images. Scale bars signify 100 m. 
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Figure 17.  DGAT enzyme transcript abundance with PA and OA exposure. 
A) DGAT1 (N=3, P>0.05, One-Way ANOVA), B) DGAT2 (N=3, P>0.05, One-Way 
ANOVA). Bars represent mean fold-change in mRNA abundance relative to the control + 
SD.  
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3.4 Effects of OA and PA on mitochondrial superoxide 
abundance 
Finally, to assess whether exposure to PA or OA treatment affected preimplantation mouse 
embryonic mitochondrial superoxide levels, embryos exposed to PA treatment alone or in 
combination with OA were incubated with MitoSox Red.  Mitochondrial superoxide 
produced by embryos exposed to PA treatment alone or in combination with 50 M OA 
did not differ significantly from untreated control embryos (Figures 18-19). Importantly, 
mitochondrial superoxide levels were significantly lower in embryos exposed to PA in 
combination with 100 M (P=0.0043) or 250 M (P=0.0064) OA (Figures 18-19).  Thus, 
OA treatment displayed an ability to reduce basal levels of mitochondrial superoxide in 
culture. 
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Figure 18. MitoSox fluorescence in mouse embryos with PA and OA exposure.  
Confocal images of live preimplantation embryos after culture in NEFAs and MitoSox Red 
staining. A) Light images of embryos. B) Fluorescent images of MitoSox Red staining. 
Media noted as lowercase letters were a) control embryos, b) 100 M PA, c) 50 M OA 
with 100 M PA, d) 100 M OA with 100 M PA, and e) 250 M OA with 100 M PA. 
Images were taken using a confocal microscope and 10x objective lens. Scale bars signify 
50 m. 
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Figure 19. Quantified mitochondrial superoxide levels. 
A) Quantified MitoSox Red fluorescence in embryos cultured from the 2-cell stage for 46 
hours in PA or OA alone or in combination (N=19-28, P<0.0001, One-Way ANOVA). 
Bars represent mean MitoSox fluorescence per embryo with + standard error (SE). Data is 
presented in fluorescence units with background fluorescence subtracted. Bars with 
different letters are statistically significant according to Tukey’s multiple comparisons test.  
Representative higher magnification views of MitoSox Red fluorescence in control (B) and 
100  PA (D) and their corresponding light microscope (C, E) images. Scale bars signify 
50 m. 
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Chapter 4  
4 Discussion 
Treatment of different tissues with PA and OA has been investigated thoroughly, with 
several studies indicating that PA and OA have differential effects on tissue and cell 
survival74,123. OA is generally regarded to have protective effects against PA-induced 
effects. A previous study demonstrated that PA exposure of preimplantation embryos at 
the blastocyst stage resulted in reduced blastocyst cell numbers and IUGR72. Wang and 
Tsujii investigated the differences in lipid handling in the preimplantation embryo with PA 
and OA and found that PA and OA were incorporated at different rates and into different 
compartments in the mouse preimplantation embryo124. However, prior to this thesis, the 
differential effects of combined PA and OA exposure to mouse preimplantation 
development and the resulting mechanistic alterations were minimally studied.  
The purpose of this research was two-fold. First, we aimed to better understand how 
NEFAs PA and OA affects preimplantation embryo development and the mechanisms 
altered by NEFA exposure. Second, adding NEFAs to in vitro embryo culture media 
provides insight into possible approaches that could be made in clinics when culturing 
embryos for fertility treatments. This is because associations can be made between mouse 
embryo developmental competence and mechanistic changes that occur as a result of in 
vitro culture. Translating these findings into human fertility clinics could improve human 
embryo viability. Using an in vitro mouse model, this purpose was fulfilled by exposing 
two-cell embryos to OA alone or in combination with PA. Our primary hypothesis was that 
OA exposure from the two-cell stage onward would attenuate PA-induced reductions in 
the proportion of mouse embryos developing to the blastocyst stage. This hypothesis was 
tested in three aims which not only investigated the outcome of NEFA exposure on 
blastocyst development, but also the mechanisms underlying these effects. Our primary 
aims were to: 1) define the effects of OA on preimplantation development, 2) define the 
effects of co-culture with PA and OA on preimplantation development, and 3) investigate 
the mechanisms implicated in other tissues regarding PA and OA exposure, but in the 
mouse preimplantation embryo.  
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4.1 Preimplantation Development with OA 
For Aim 1 the effect of OA exposure alone was investigated in experiment 1 by exposing 
two-cell embryos to increasing concentrations of OA in vitro for a 46-hour culture period. 
We hypothesized that in contrast to PA which reduces embryos’ capacity to develop 
to the blastocyst stage during this period, OA would not affect blastocyst development.  
When developmental stage of the embryos after culture was visually assessed through 
phase contrast microscopy, the percentage of embryos that had reached the blastocyst stage 
with OA at all concentrations tested was no different than controls. This novel and 
intriguing finding contrasted greatly to the discovery I made during my undergraduate 
thesis (Appendix A), where concentrations of PA as low as 50 M decreased the proportion 
of embryos developing to the blastocyst stage. These PA levels, which were ten-fold lower 
than the 500 M OA treatment, were capable of interfering with preimplantation mouse 
development to impair an embryo’s capacity to develop to the blastocyst stage in culture. 
The PA and OA were included in culture conjugated to BSA such that increasing PA or 
OA content the medium would increase the BSA content to which embryos were exposed. 
Controls accounting for the highest and lowest BSA content were included and confirmed 
that the high BSA content did not alter blastocyst development. This showed that with 
higher OA concentration, BSA content was not a confounding factor in and of itself and 
was not harmful or beneficial to embryo culture. When investigating the role of PA and 
OA in placental trophoblasts, Colvin et al. exposed trophoblast cells to normal or obese 
levels of PA and OA63. In lean individuals, PA and OA are each found at roughly 100 M 
concentrations in human serum, however concentrations are higher in obese individuals at 
200-400 M each58,63,64. The concentrations of PA and OA in this and my study were very 
low relative to serum levels in obese patients. Thus, the results of this experiment may not 
be representative of in vivo effects, however, they contribute to our understanding of an 
embryo’s in vitro tolerance to NEFA exposure. These results clearly illustrate that PA and 
OA have very different effects on the preimplantation mouse embryo, where substantially 
higher concentrations of OA did not alter the embryos’ development to the blastocyst stage. 
Thus, our hypothesis was supported by the results of this experiment. This study provides 
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the first reports of PA and OA exposure differentially affecting the proportion of embryos 
reaching the blastocyst stage during a culture period.  
4.2 Preimplantation embryo development with PA and OA 
co-culture 
For Aim 2 the effect of PA and OA co-culture was investigated through experiment 2 
by exposing 2-cell mouse embryos to 100 M of PA alone or in combination with either 
50, 100 or 250 M of OA in vitro for a 46-hour culture period. The effect of NEFA 
exposure has been investigated in bovine oocytes71,125,126 and mouse follicles127.  
We hypothesized that OA would attenuate PA-induced reductions in the proportion 
of embryos developing to the blastocyst stage  
A PA-only treatment was included with each experimental replicate. This 100 M PA 
treatment confirmed the finding from my undergraduate thesis that PA decreases the 
proportion of embryos reaching the blastocyst stage relative to controls.  When both PA 
and OA were included in embryo culture media, embryos developed to the blastocyst stage 
in similar proportions to controls. In other tissues and cell types the protective effect of OA 
is well established. For example, in syncytiotrophoblasts, Colvin et al. found that OA 
blunted PA-induced decreases in viability, induction of apoptosis and ER stress63. Fayezi 
et al. summarized the current knowledge of OA’s effects in the female reproductive tract110. 
They found that the protective effect of OA is well defined earlier in reproduction, 
particularly in the ovarian follicle and oocyte. However, the developmental and 
mechanistic effects of PA and OA during preimplantation embryo development are not 
well defined. This novel finding further solidifies and supports the fact that PA and OA 
have very different effects on embryo development. Specifically, OA has a protective 
effect on embryo development and is capable of dampening the negative effect of PA. 
Interestingly, the relatively lower concentration of 50 M OA was able to prevent the 
developmental impairment caused by 100 M PA. Thus, this result in combination with 
the result of Aim 2 shows that PA has a potent negative effect on blastocyst development 
at 50 M, where 50 M OA has a potent protective effect when in combination with PA, 
but not alone. Overall, OA did not increase the proportion of embryos developing to the 
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blastocyst stage relative to control media. Since combinatory exposure of embryos to PA 
and OA prevented PA-induced decreases, it is possible that OA prevents mechanistic 
changes that cause lipotoxicity with PA exposure. The proportion of embryos after culture 
being at the 8-cell stage or earlier was significantly higher with PA only, however this was 
not observed when embryos were co-cultured in both PA and OA. The results of 
experiment 2 supported our hypothesis and demonstrated that OA attenuates impairments 
in blastocyst development that are seen with PA exposure.  
The rate or frequency of development of an embryo is a key marker of embryo viability128. 
This can be assessed as the number of cells within an embryo at a certain time point128. 
Although blastocyst cell numbers were not assessed in this study, the fact that embryos 
exposed to OA alone or in combination with PA were able to reach the blastocyst stage 
within a normal culture period is indicative of viability and likely capacity to initiate a 
pregnancy. Given the culture period was terminated 46 hours into NEFA treatment when 
the majority of embryos exposed to PA alone did not reach the blastocyst stage, overall 
embryo developmental competence or viability was not fully tested. Failure to reach the 
blastocyst stage in the experimental treatment time is not a fully reliable measure of their 
capacity to reach the blastocyst stage overall. It is possible that the PA treatment simply 
slowed down or delayed preimplantation embryo development and that if these embryos 
were left in culture longer, they would progress further and reach the blastocyst stage. 
Regardless, the significantly decreased progression throughout preimplantation 
development that was observed is an ominous sign and is highly suggestive of decreased 
embryo viability even if the blastocyst stage is reached. In vivo studies are needed to 
investigate this. Additionally, morphological assessment of PA-treated embryos displayed 
uneven blastomeres and some cell fragmentation, both of which are signs of reduced 
embryo developmental competence128,129. These morphological changes did not occur with 
PA and OA co-treatment, suggesting that mouse embryos that were exposed to OA likely 
have greater viability.  
A recent review by Fayezi et al.110 outlined the most likely mechanisms through which OA 
exerts its protective effect in the preimplantation embryo. These included but were not 
limited to 1) altering TAG synthesis, 2) reducing oxidative stress, as well as 3) altering 
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energy production. As was presented in the introduction to this thesis, many publications 
have found that PA and OA have opposing effects on ER stress80,83,93, which suggests that 
the ER stress response may be similarly affected in preimplantation mouse embryos. When 
investigating the protective effect of OA in beta cells, Sargsyan et al. concluded that PA 
alters mitochondrial function and induces ER stress119. They found that OA protected 
against this through upregulation of chaperones and antioxidant production119. Given that 
developmentally our results confirmed that PA was detrimental to preimplantation mouse 
embryo development and that OA was protective against these effects, we predicted that 
these mechanisms that were altered in other tissues would also be changed in the mouse 
preimplantation embryo.  
For Aim 3 the mechanisms underlying the effects of PA and OA exposure were 
investigated in experiment 2. After 2-cell embryos were cultured in PA alone or in 
combination with either 50, 100 or 250 M OA, development was assessed as presented in 
aim 2, and these same embryos were processes downstream to assess mechanistic changes.  
4.2.1 ER Stress with PA and OA 
We hypothesized that PA would elevate ER stress pathway constituent mRNA levels 
and that this effect would be attenuated by co-culture with OA.  
In rat liver hepatoma cells 500 M PA treatment induced ER stress and activated the PERK 
and IRE1 arms of the UPR in response83. ER stress was indicated by PERK and IRE1 
phosphorylation, and XBP1 splicing upon PA exposure83. Given that previous publications 
investigated ER stress in tissues exposed to PA63,79,83,84,86,115,117,130,131, we assessed the UPR 
pathway in these embryos through RT-PCR for XBP1 splicing, and quantitative RT-PCR 
for CHOP, ATF3 and ATF6. Altogether, this experiment investigated the three different 
arms of the UPR, with ATF3 and CHOP falling under the PERK arm, XBP1 splicing as a 
marker of the IRE1 arm, and ATF6 falling under its own arm. As is consistent with 
previous studies, PA induces ER stress, but OA does not132. In our study, OA alone did not 
affect ATF3 or CHOP transcript abundance, suggesting that the UPR was not affected by 
this treatment. This aligns with past studies where OA treatment alone did not induce ER 
stress80. However, a key limitation of this outcome is that UPR regulation was not 
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investigated in NEFA-exposed embryos. Many UPR pathway members are regulated 
through posttranslational modifications, such as phosphorylation of PERK, IRE1 and 
ATF6. Protein phosphorylation can be assessed through Western Blotting, however the 
low protein abundance in mouse preimplantation embryos makes these experiments 
technically challenging to successfully perform and would require large embryo pools for 
subsequent analyses.  The UPR may be activated with OA exposure, however, my results 
do not support this possibility. However, exposure to 100 M PA increased XBP1 splicing, 
and elevated CHOP and ATF3 relative transcript abundance, but did not affect ATF6 
transcript levels. This PA-induced activation of the PERK and IRE1 arms of the UPR did 
not occur when OA was included in embryo culture media. Again, these results are 
consistent with the growing conclusion that OA is protective against PA’s effects, 
specifically in that it prevents PA-induced ER stress80 in mouse preimplantation embryos. 
Our hypothesis that OA would dampen PA-induced ER stress was supported by the results 
present within this thesis. 
4.2.2 Lipid Droplet Accumulation with PA and OA 
We hypothesized that culture of embryos in PA or OA results in altered lipid 
handling – with OA resulting in increased lipid droplet accumulation. 
A recent paper by Piccolis et al. reported that when human leukemia cells were exposed to 
PA, a primary mechanism responsible for lipotoxicity was ER stress which was associated 
with an accumulation of PA and DAGs in the cells85. In primary NCMs, PA but not OA 
induced ER stress, however both NEFAs increased LD accumulation80. Interestingly, in 
cardiomyocytes, PA reduced LD levels81. In HepG2 cells treatment with 300 M PA 
increased triglyceride levels and lipid droplet accumulation relative to controls131.  
OA, but not PA, induced lipid droplet accumulation in mouse preimplantation embryos. 
Inclusion of OA concentrations equal to or higher than the 100 M PA in co-culture 
resulted in lipid droplet accumulation that was significantly higher than control, PA-only 
or OA-only treated embryos. Embryos co-treated with PA and either 50 or 100 M OA 
showed significant differences in LD accumulation where only embryos co-treated with 
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100 M OA displayed significantly greater LD accumulation. Given that the 50 M 
concentration of OA was not capable of increasing LD accumulation this result suggests 
that PA has an inhibitory effect on LD accumulation. Increasing the OA treatment to 100 
M dramatically increased LD accumulation. This concentration-response effect of OA 
was an unexpected but intriguing finding. Future experiments should be conducted 
investigating the concentration response effect of OA alone to elucidate whether this jump 
in LD accumulation is an OA-induced effect or if this is a consequence of PA and OA co-
treatment.  
When quantified, there was no difference in BODIPY fluorescence in PA-treated embryo 
from controls. However, this may not be indicative of there being similar lipid droplet 
numbers with PA treatment. Morphologically, staining in OA-treated embryos showed 
defined circular punctate spots, which aligns with lipid droplet morphology80. However, 
BODIPY fluorescence in PA-treated embryos was diffuse and did not contain as many 
punctate, lipid droplet areas of staining80. This diffuse staining cannot be attributed to 
background staining given that it was not present in the no-NEFA treated controls and 
negative BODIPY control80.  
Relative transcript levels of DGAT1 and DGAT2 were not affected by PA or OA treatment. 
If DGAT2 levels or activity were lower with PA treatment, this would result in decreased 
TAG synthesis, which provides less substrate for storage in lipid droplets. It is possible that 
PA exposure does not affect DGAT2 transcript abundance, as was shown by our results, 
but rather acts at the translational or post-translational level. Given that DGAT2 is an 
enzyme, it is possible that PA and OA differentially affect regulation of DGAT2 activity, 
which downstream results in differential TAG and lipid droplet levels. Collectively, these 
findings and conclusions support our hypothesis that OA directs accumulation of 
cytoplasmic lipid droplets.  
4.3 Mitochondrial Superoxide Levels with PA and OA 
We hypothesized that PA would increase mitochondrial superoxide levels and that 
this would be attenuated by OA in co-culture.  
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Multiple studies have established that PA treatment often results in mitochondrial 
dysfunction133. To consider this effect in preimplantation embryos, mitochondrial 
superoxide levels in embryos exposed to PA alone or in combination with OA were 
quantified. Studies have suggested that PA alone will increase mitochondrial superoxide 
levels, as has been measured using MitoSox Red fluorescent dye114,133–135. When OA was 
added to skeletal myotubes cultured in PA, the PA-induced increase in MitoSox 
fluorescence was dampened. This was yet another mechanism which hinted at the 
mechanisms underlying the protective effects of OA against PA.  
Embryos cultured in control or combinatorial treatments developed in similar proportions 
to the blastocyst stage. However, mitochondrial superoxide levels for these treatments were 
significantly different and thus, superoxide levels did not align with the developmental 
data. The embryos cultured in control, PA alone or PA co-cultured with 50 M OA did not 
vary in the levels of detectable mitochondrial superoxide. Compared to these groups, 
embryos co-cultured with PA and 100 or 250 M OA produced significantly less 
mitochondrial superoxide. Thus, although 100 M PA alone did not alter mitochondrial 
superoxide levels, OA treatment was demonstrated to lower these levels. Based on these 
collective results, I concluded that differential mitochondrial superoxide levels were not 
directly correlated with the developmental differences observed with PA and OA exposure 
in mouse preimplantation embryos. OA was capable of overpowering the PA-induced 
effect to produce a different result. The results of this study did not support our hypothesis. 
However, the differences in mitochondrial superoxide levels may not be indicative of 
mitochondrial superoxide production. Superoxide dismutase (SOD) is an enzyme that 
processes superoxide molecules into the less harmful hydrogen peroxide (H2O2) and O2
136. 
Differential effects seen with PA and OA exposure could be due to alterations in SOD 
activity rather than mitochondrial activity. Future studies could assess SOD abundance in 
preimplantation mouse embryos treated with PA and/or OA.  
With OA it is possible that more TAG synthesis occurred, resulting in less being oxidized. 
These TAGs are likely incorporated into LDs, which we showed in Figure 16 to 
accumulate with OA treatment. Given that TAGs are the primary cellular energy source110 
and ATP is produced in the mitochondria, it is possible that mitochondrial activity is 
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reduced with OA, which in turn would reduce mitochondrial superoxide production (as 
was seen in our results, Figure 19).  
4.4 Limitations and Future Directions 
The research I conducted throughout this thesis is valuable because it showed that PA and 
OA do in fact affect mouse preimplantation embryo physiology and development. This 
study lays the groundwork for understanding how the most abundant NEFAs, PA and OA, 
affects embryos’ progression through preimplantation development and the mechanisms 
altered by NEFA exposure. As with any study, I used the information available in the 
literature at the time to answer our specific question. Limitations of this study can be 
addressed through future work (Figure 20). The concentrations of PA and OA in this study 
were modeled off of follicular fluid phospholipid levels and serum NEFA levels. The 
NEFA levels in the reproductive tract are not known at this time. Mass spectrometry should 
be applied to characterize the NEFA content of the reproductive tract in both mice and 
humans. This study concluded that PA induces ER stress, and that this is attenuated by OA 
in mouse preimplantation embryos. The most definitive marker of this is XBP1 splicing, 
however other markers of the UPR that were assessed at the transcriptional level are 
regulated post-translationally. Thus, assessing transcript levels may not be reflective of 
abundance of the functional proteins or their effects. Future research should assess 
regulation (ex. phosphorylation using immunocytochemistry) of UPR markers, such as 
PERK, IRE1 and ATF6, which would more definitively determine which arms of the UPR 
are activated with PA and OA treatment.  
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Figure 20. Summary Figure: Limitations and future work 
Key limitations and suggested future work to address current gaps in knowledge. 
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The results indicate that OA treatment is protective against the negative effects of PA 
treatment. Additional research should be conducted through our mouse model both in vitro 
and in vivo to explore the extent of this protective effect. Exposing mouse 2-cell embryos 
to NEFA for a prolonged period and altering the culture period timing and stage of culture 
in NEFAs will help us understand differences in the preimplantation embryo at different 
stages as well as differences with brief and prolonged NEFA exposure. For example, a 
future experiment could entail briefly culturing mouse preimplantation embryos in OA for 
a few hours and transferring these embryos into a PA-only treatment for the remainder of 
the 46-hour culture period. Such an experiment provides insight into whether OA treatment 
has long term protective effects in the embryo and whether such a treatment could be used 
in clinics for obese future mothers’ embryos. This experiment is directly translatable and 
makes use of our in vitro mouse system to model how in vitro exposure to OA could 
developmentally predispose an embryo for success once transferred into the high PA 
maternal environment. A key limitation of these NEFA treatment experiments is that 
uptake of PA and OA was not confirmed. Such experiments would have been too resource 
and time intensive to complete in the time that was available. It is possible that PA and OA 
are differentially taken up by mouse preimplantation embryos. This could be assessed by 
treating embryos with radioactively labeled PA and OA and quantifying their abundance 
in the embryos after the culture period.  
In vitro studies are an essential aspect of clinically translatable research; however, it is 
necessary that in vivo research be conducted before these findings can be applied in human 
fertility clinics. Our lab focuses on mouse preimplantation embryo development which 
terminates before a blastocyst implants in the uterus. However, it is important to remember 
that although blastocyst development is essential, the more important and key factor is 
blastocyst viability. Future in vivo studies should involve transferring embryos matured in 
NEFAs in vitro to a mouse surrogate mother for implantation, miscarriage and live birth 
rate assessments. Such studies should assess the dose-response effect of PA and OA alone 
on embryo viability. Genetic screening tools such as microarrays137 or RNA-seq138 could 
be used to characterize the transcriptional landscape of embryos exposed to these different 
NEFAs. Correlations between viability and transcript levels in mouse embryo studies could 
prove to be applicable in human fertility clinics. Additionally, microarrays of individual 
61 
 
embryos could provide insight into how an embryos’ genetics and developmental capacity 
are related.  
Finally, the results presented in this thesis showed that PA and OA differentially affect 
alterations in ER stress, LD accumulation and mitochondrial superoxide. The relationship 
between these mechanisms and changes must be investigated further. For example, a 2018 
study investigating ER stress in nonalcoholic fatty liver disease discovered that PA 
exposure with HEPG2 cells caused Ca2+ release from the ER lumen via IP3 expression, 
which subsequently induced ER stress131. PA also induced apoptosis and Ca2+ release from 
the ER in mouse podocytes139. However, when HEPG2 cells were transfected with 
augmented liver regeneration (ALR), PA exposure had the opposite effect on IP3 
expression, which decreased ER Ca2 release and ER stress131. Xiao et al. linked PA-induced 
release of Ca2 with increased uptake of Ca2 into the mitochondria131, which is a possible 
mechanism through which ER function and stress may be integrated with mitochondrial 
function following NEFA exposure. Additionally, the metabolic fate and shuttling of PA 
and OA into different lipid compartments (ex. TAG, DAG, phospholipids, etc.), can be 
assessed using mass spectrometry.  
4.5 Conclusions and Significance 
PA and OA have different effects in many tissues, with PA showing to be apoptotic. OA 
is protective against PA’s effects. Many mechanisms, such as mitochondrial dysfunction, 
ER stress and differential lipid metabolism are implicated in PA’s effects. The overall 
objective of this thesis was to investigate the effect of these two NEFAs on preimplantation 
development and elucidate the mechanisms that are altered with PA and OA exposure. Our 
overall findings are summarized in Figure 21.  
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Figure 21. Summary Figure: Effects of PA and OA on preimplantation mouse 
embryos. 
Summary of findings defining the differential effects of PA and OA within culture from 
the 2-cell stage for 46 hours in mouse preimplantation embryos.  
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We discovered that PA impairs the preimplantation embryo’s capacity to reach the 
blastocyst stage. Rather, embryos primarily arrested at the 8-cell stage and earlier.  OA 
dampened this PA-induced effect. This thesis reports novel outcomes demonstrating OA 
treatment’s ability to be protective in the mouse preimplantation embryo against these 
effects. The cumulative effects of elevated ER stress, lipid droplet accumulation and 
increased mitochondrial superoxide levels all represent adaptive responses by the early 
embryo in the face of elevated PA exposure. The results are consistent with responses and 
mechanisms observed in other tissues. Overall, while this thesis reports outcomes from 
applying a single experimental design in which 2-cell stage mouse embryos were treated, 
it does lay an important foundation to our eventual complete understanding of the 
detrimental and likely beneficial effects of NEFA exposure on preimplantation 
development. This information is vital to our understanding of the influence of obesity on 
human fecundity and it is our hope that with time and further investigation the outcomes 
from this thesis will be incorporated into therapeutic approaches that will benefit pregnancy 
outcomes of all patients seeking the services of fertility clinics to conceive, and especially 
so for the obese patient. Investigating the extent of OA’s protective effects using different 
culture concentrations and times of exposure could contribute to improving our 
understanding of embryo physiology and why preimplantation embryos respond 
differently to different NEFAs.   
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Appendix A: Dose response to PA 
Before this thesis, I investigated the dose response effect of PA on preimplantation mouse 
embryo development. I exposed 2-cell mouse embryos to increasing concentrations of 
palmitic acid which was conjugated to BSA. The duration of culture, which was 46 hours, 
was identical to the culture period for experiments presented in this thesis. Development 
to the blastocyst stage was visually assessed under a phase contrast microscope and is 
reported in Supplementary Figure 1. Relative to controls, 10 and 25 M PA did not affect 
the proportion of embryos developing to the blastocyst stage. However, 50 M PA reduced 
the percentage of embryos that were able to develop to the blastocyst stage after the 46-
hour culture period.  
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Supplementary Figure 1. Dose response effect of PA on blastocyst percentage. 
Two-cell mouse embryos were cultured in PA at different concentrations conjugated to 
BSA. Culture of embryos in 10 and 25 M PA resulted in blastocyst percentages that were 
not significant from control embryos, however culture in 50 M PA significantly reduced 
blastocyst percentage. Bars represent the mean percentage of embryos at the blastocyst 
stage + SD. Bars with different letters are statistically significant according to Tukey’s 
multiple comparisons test.  
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